SEC Clinical Research is a clinical research site located in Andalusia, Alabama, United States 36420.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
SEC Clinical Research has participated in 8 clinical trials with 3 currently active.
Therapeutic areas: Cardiovascular Disease and Lipoprotein(a), Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease.
Sponsors: Novartis Pharmaceuticals, Galecto Biotech AB, Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Andalusia
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SEC Clinical Research has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SEC Clinical Research has 8 clinical trials on record, with 3 currently active. Their work covers Cardiovascular Disease and Lipoprotein(a), Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease.
SEC Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.